CompletedNCT03372993
Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven
Studying Congenital factor VII deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AryoGen Pharmed Co.
- Principal Investigator
- Mohammad Faranoush, MDHazrat Rasool Akram Hospital, MAHAK Children's Hospital, Iran University of Medical Sciences, Tehran
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2021
Study locations (2)
- Iranian Blood Transfusion Organization (IBTO), Tehran, Iran
- MAHTA (Iranian Hemophilia and Thrombophilia Association), Tehran, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03372993 on ClinicalTrials.govOther trials for Congenital factor VII deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07347249A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII DeficiencyHemab ApS
- RECRUITINGPHASE1NCT06349473A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)Equilibra Bioscience LLC